SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-044593
Filing Date
2024-04-16
Accepted
2024-04-16 07:14:39
Documents
56
Period of Report
2024-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cgem-20240415.htm   iXBRL 8-K 100502
2 EX-3.1 cgem-ex3_1.htm EX-3.1 10856
3 EX-3.2 cgem-ex3_2.htm EX-3.2 192876
4 EX-10.1 cgem-ex10_1.htm EX-10.1 458507
5 EX-10.2 cgem-ex10_2.htm EX-10.2 176646
6 EX-10.3 cgem-ex10_3.htm EX-10.3 113453
7 EX-99.1 cgem-ex99_1.htm EX-99.1 20120
8 EX-99.2 cgem-ex99_2.htm EX-99.2 36242
9 EX-99.3 cgem-ex99_3.htm EX-99.3 42675
10 GRAPHIC cgem-ex99_3s1.jpg GRAPHIC 391575
11 GRAPHIC cgem-ex99_3s2.jpg GRAPHIC 1132426
12 GRAPHIC cgem-ex99_3s3.jpg GRAPHIC 352168
13 GRAPHIC cgem-ex99_3s4.jpg GRAPHIC 415953
14 GRAPHIC cgem-ex99_3s5.jpg GRAPHIC 537312
15 GRAPHIC cgem-ex99_3s6.jpg GRAPHIC 350575
16 GRAPHIC cgem-ex99_3s7.jpg GRAPHIC 417168
17 GRAPHIC cgem-ex99_3s8.jpg GRAPHIC 429504
18 GRAPHIC cgem-ex99_3s9.jpg GRAPHIC 378130
19 GRAPHIC cgem-ex99_3s10.jpg GRAPHIC 371476
20 GRAPHIC cgem-ex99_3s11.jpg GRAPHIC 367838
21 GRAPHIC cgem-ex99_3s12.jpg GRAPHIC 448675
22 GRAPHIC cgem-ex99_3s13.jpg GRAPHIC 466830
23 GRAPHIC cgem-ex99_3s14.jpg GRAPHIC 291212
24 GRAPHIC cgem-ex99_3s15.jpg GRAPHIC 409994
25 GRAPHIC cgem-ex99_3s16.jpg GRAPHIC 325093
26 GRAPHIC cgem-ex99_3s17.jpg GRAPHIC 526666
27 GRAPHIC cgem-ex99_3s18.jpg GRAPHIC 451833
28 GRAPHIC cgem-ex99_3s19.jpg GRAPHIC 419005
29 GRAPHIC cgem-ex99_3s20.jpg GRAPHIC 383250
30 GRAPHIC cgem-ex99_3s21.jpg GRAPHIC 369028
31 GRAPHIC cgem-ex99_3s22.jpg GRAPHIC 378437
32 GRAPHIC cgem-ex99_3s23.jpg GRAPHIC 292193
33 GRAPHIC cgem-ex99_3s24.jpg GRAPHIC 579031
34 GRAPHIC cgem-ex99_3s25.jpg GRAPHIC 360584
35 GRAPHIC cgem-ex99_3s26.jpg GRAPHIC 306355
36 GRAPHIC cgem-ex99_3s27.jpg GRAPHIC 343949
37 GRAPHIC cgem-ex99_3s28.jpg GRAPHIC 514606
38 GRAPHIC cgem-ex99_3s29.jpg GRAPHIC 495077
39 GRAPHIC cgem-ex99_3s30.jpg GRAPHIC 434051
40 GRAPHIC cgem-ex99_3s31.jpg GRAPHIC 363029
41 GRAPHIC cgem-ex99_3s32.jpg GRAPHIC 340212
42 GRAPHIC cgem-ex99_3s33.jpg GRAPHIC 417760
43 GRAPHIC cgem-ex99_3s34.jpg GRAPHIC 377521
44 GRAPHIC cgem-ex99_3s35.jpg GRAPHIC 397739
45 GRAPHIC cgem-ex99_3s36.jpg GRAPHIC 389033
46 GRAPHIC cgem-ex99_3s37.jpg GRAPHIC 400704
  Complete submission text file 0000950170-24-044593.txt   22983345

Data Files

Seq Description Document Type Size
47 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cgem-20240415.xsd EX-101.SCH 27989
59 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20240415_htm.xml XML 5307
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 24846101
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)